Makoto Ota
Founder en WELBE, INC. .
Fortuna: 39 M $ al 31/03/2024
Perfil
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
WELBE,INC.
20.00% | 27/03/2024 | 5 512 154 ( 20.00% ) | 39 M $ | 31/03/2024 |
Cargos activos de Makoto Ota
| Empresas | Cargo | Inicio |
|---|---|---|
| WELBE, INC. | Founder | 01/12/2011 |
| Welbe Healthcare, Inc. | Director/Board Member | 01/06/2021 |
Antiguos cargos conocidos de Makoto Ota.
| Empresas | Cargo | Fin |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Makoto Ota
